Granahan Investment Management LLC lessened its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 12.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 663,981 shares of the company’s stock after selling 95,970 shares during the quarter. Granahan Investment Management LLC’s holdings in OrthoPediatrics were worth $11,792,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of KIDS. Russell Investments Group Ltd. boosted its stake in OrthoPediatrics by 433.1% during the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after buying an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after buying an additional 2,561 shares during the period. Caption Management LLC purchased a new position in OrthoPediatrics during the third quarter worth about $54,000. BNP Paribas Financial Markets boosted its stake in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the period. Finally, State of Wyoming boosted its stake in shares of OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock valued at $121,000 after purchasing an additional 4,467 shares during the period. Hedge funds and other institutional investors own 69.05% of the company’s stock.
OrthoPediatrics Stock Up 2.1%
Shares of NASDAQ:KIDS opened at $18.53 on Wednesday. The firm’s 50 day moving average price is $17.21 and its 200 day moving average price is $17.42. The stock has a market cap of $475.94 million, a price-to-earnings ratio of -11.03 and a beta of 1.03. OrthoPediatrics Corp. has a fifty-two week low of $14.42 and a fifty-two week high of $23.70. The company has a quick ratio of 2.37, a current ratio of 5.21 and a debt-to-equity ratio of 0.29.
Analyst Ratings Changes
Several research analysts have recently commented on KIDS shares. BTIG Research reissued a “buy” rating and issued a $24.00 price objective on shares of OrthoPediatrics in a research note on Friday, May 1st. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research note on Saturday, March 7th. Canaccord Genuity Group set a $25.00 price objective on shares of OrthoPediatrics in a research note on Friday, April 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Tuesday, April 21st. Finally, TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research note on Monday. Nine research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $24.44.
Read Our Latest Stock Analysis on OrthoPediatrics
About OrthoPediatrics
OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.
The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.
Featured Stories
- Five stocks we like better than OrthoPediatrics
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report).
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
